Betamethasone Valerate + Gentamicin Sulfate + Tolnaftate + Clioquinol 500mcg + 1mg + 10mg + 10mg pergram Cream, topical الفلبين - الإنجليزية - FDA (Food And Drug Administration)

betamethasone valerate + gentamicin sulfate + tolnaftate + clioquinol 500mcg + 1mg + 10mg + 10mg pergram cream, topical

lloyd labs inc - betamethasone valerate , gentamicin sulfate , tolnaftate , clioquinol - cream, topical - 500mcg + 1mg + 10mg + 10mg pergram

Betnovate C نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

betnovate c

glaxosmithkline nz limited - betamethasone valerate 0.1%{relative}; clioquinol 3%{relative};   - topical cream - 0.1%/3% - active: betamethasone valerate 0.1%{relative} clioquinol 3%{relative}   - betnovate-c preparations are indicated for the treatment of the following conditions where secondary bacterial and/or fungal infection is present, suspected or likely to occur:- eczema including atopic, and discoid eczemas. prurigo nodularis. psoriasis (excluding widespread plaque psoriasis). neurodermatoses including lichen simplex, lichen planus. seborrhoeic dermatitis. contact sensitivity reactions. insect bite reactions. prickly heat. anal and genital intertrigo. otitis externa.

Betamethasone valerate 0.1% / Clioquinol 3% cream المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% / clioquinol 3% cream

alliance healthcare (distribution) ltd - betamethasone valerate; clioquinol - cutaneous cream - 1mg/1gram ; 30mg/1gram

Betamethasone valerate 0.1% / Clioquinol 3% ointment المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

betamethasone valerate 0.1% / clioquinol 3% ointment

alliance healthcare (distribution) ltd - betamethasone valerate; clioquinol - cutaneous ointment - 1mg/1gram ; 30mg/1gram